Nina Niu Sanford: A balanced editorial of MR-guided RT
JAMA Oncology shared a post on X, about recent paper published in JAMA Oncology:
MRI-Linac–Based Radiotherapy—Promising or Hype?
Authors: Mack Roach,Stella Ling, Pamela W. Coleman.
”Viewpoint discusses the value of magnetic resonance imaging with linear accelerator (MRI-linac) technology, given the unmet needs in its development.”
Nina Niu Sanford shared JAMA Oncology’s post on X, adding:
”This is a balanced editorial of MR-guided RT.
Like any other RT technology, there is both promise and hype.
I think we all recognize scenarios where we think MR is very helpful, but can also acknowledge that current policies permit its use for cases with likely 0 clinical benefit.”
Source: JAMA Oncology/X and Nina Niu Sanford/X
Nina Niu Sanford is an Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital. She specializes in treating gastrointestinal cancers and actively participates in clinical trials combining high-dose radiation therapy with immunotherapy. Additionally, she researches healthcare access disparities and conducts pan-cancer outcomes research using large databases.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023